Accession Number: | 0000899243-21-038540 |
Date: | 2021-09-28 |
Issuer: | TERNS PHARMACEUTICALS, INC. (TERN) |
Original Submission Date: |
QUIGLEY JILL M.
C/O TERNS PHARMACEUTICALS, INC.
1065 EAST HILLSDALE BLVD., SUITE 100
FOSTER CITY, CA 94404
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 10.72 | 2021-09-28 | deemed execution date | A | 22,000 (a) | 2031-09-28 | common stock 22,000 | $10.72 | 22,000 | direct |
ID | footnote |
---|---|
f1 | 1/3rd of the shares subject to the option vest on the first anniversary measured from september 28, 2021 (the "vesting commencement date"), and 1/36th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the third anniversary of the vesting commencement date. |